Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Analysis of Overall Level of Evidence Behind Infectious Diseases Society of America Practice Guidelines

Analysis of Overall Level of Evidence Behind Infectious Diseases Society of America Practice... ORIGINAL INVESTIGATION Analysis of Overall Level of Evidence Behind Infectious Diseases Society of America Practice Guidelines Dong Heun Lee, MD; Ole Vielemeyer, MD Background: Clinical practice guidelines are devel- percent of the recommendations were classified as level oped to assist in patient care. Physicians may assume that I, 31% as level II, and 55% as level III evidence. Among following such guidelines means practicing evidence- class A recommendations (good evidence for support), based medicine. However, the quality of supporting lit- 23% were level I (1 randomized controlled trial) and erature can vary greatly. 37% were based on expert opinion only (level III). Up- dated guidelines expanded the absolute number of indi- Methods: We analyzed the strength of recommenda- vidual recommendations substantially. However, few were tion and overall quality of evidence behind 41 Infec- due to a sizable increase in level I evidence; most addi- tious Diseases Society of America (IDSA) guidelines re- tional recommendations had level II and III evidence. leased between January 1994 and May 2010. Individual recommendations were classified based on their strength Conclusions: More than half of the current recommen- of recommendation (levels A through C) and quality of dations of the IDSA are based on http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Analysis of Overall Level of Evidence Behind Infectious Diseases Society of America Practice Guidelines

JAMA Internal Medicine , Volume 171 (1) – Jan 10, 2011

Loading next page...
 
/lp/american-medical-association/analysis-of-overall-level-of-evidence-behind-infectious-diseases-9GcBINRdDf
Publisher
American Medical Association
Copyright
Copyright 2011 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/archinternmed.2010.482
pmid
21220656
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL INVESTIGATION Analysis of Overall Level of Evidence Behind Infectious Diseases Society of America Practice Guidelines Dong Heun Lee, MD; Ole Vielemeyer, MD Background: Clinical practice guidelines are devel- percent of the recommendations were classified as level oped to assist in patient care. Physicians may assume that I, 31% as level II, and 55% as level III evidence. Among following such guidelines means practicing evidence- class A recommendations (good evidence for support), based medicine. However, the quality of supporting lit- 23% were level I (1 randomized controlled trial) and erature can vary greatly. 37% were based on expert opinion only (level III). Up- dated guidelines expanded the absolute number of indi- Methods: We analyzed the strength of recommenda- vidual recommendations substantially. However, few were tion and overall quality of evidence behind 41 Infec- due to a sizable increase in level I evidence; most addi- tious Diseases Society of America (IDSA) guidelines re- tional recommendations had level II and III evidence. leased between January 1994 and May 2010. Individual recommendations were classified based on their strength Conclusions: More than half of the current recommen- of recommendation (levels A through C) and quality of dations of the IDSA are based on

Journal

JAMA Internal MedicineAmerican Medical Association

Published: Jan 10, 2011

References